Compound Detail
CHEMBL5934556
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5934556 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XDHZSOHHUNDLNQ-INIZCTEOSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
390.5
MW (Da)
4.12
ALogP
5
HBA
3
HBD
87.1
PSA (Ų)
0.56
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.26
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| TGF-beta receptor type-1 CHEMBL4439 | IC50 | 6.26 | 6.26 | 551.0 | 1 |
| Activin receptor type-1B CHEMBL5310 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| TGF-beta receptor type-1 | IC50 | = | 551.0 | nM | 6.26 | In Vitro Kinase Assay: Compound of the invention were screened in an in vitro ki... | - |
| Activin receptor type-1B | IC50 | = | 1100.0 | nM | 5.96 | In Vitro Kinase Assay: Compound of the invention were screened in an in vitro ki... | - |
Data from ChEMBL 36 via Core Engine